Where does Deutsches Krebsforschungszentrum rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Deutsches Krebsforschungszentrum ranks #3,253 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Deutsches Krebsforschungszentrum hold?

Deutsches Krebsforschungszentrum holds 115 US utility patents granted between 2015 and 2025, spanning 29 technology areas.

What is Deutsches Krebsforschungszentrum's Innovation Score?

Deutsches Krebsforschungszentrum has an Innovation Score of 49.4 out of 100 (top 15% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Deutsches Krebsforschungszentrum's patent grant rate increasing or decreasing?

Deutsches Krebsforschungszentrum's recent grant velocity is -18% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Deutsches Krebsforschungszentrum's patents?

Deutsches Krebsforschungszentrum's patents average 14.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Deutsches Krebsforschungszentrum patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Deutsches Krebsforschungszentrum

Q: What technology areas does Deutsches Krebsforschungszentrum focus on?

Deutsches Krebsforschungszentrum's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 64 patents. Grants appear in 29 CPC subclasses total.

USPTO PatentsView assignee record - 115 granted patents across 29 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Deutsches ranks #3,253 of 49,997 tracked US assignees by granted-patent volume, with 115 patents across 29 technology areas.

#3,253
of 49,997 US assignees by volume: Top 15%
by Innovation Score (49.4/100): 14.2
avg claims per patent: -18%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3253 · Foreign Corporation #3,253 · 115 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MID 115 grants
TOP-DECILE #3,253/49,997
PHOTO-FINISH Cognitive Scale
CPC-FOCUS A61K · 29 areas
INNOV-PAR 49.4/100
CLAIMS-RICH 14.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -18% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Cognitive Scale, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Belimo Holding · near

49
Dassault Systemes… · near

49
Deutsches Krebsforsc… · this assignee

49
Flir Belgium Bvba · near

49
Panasonic Healthcare… · near

49
3D Lighting… · lowest

7

What this shows Deutsches's Innovation Score is 49.4/100 (top 15% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Deutsches's grants concentrate

Deutsches Krebsforschungszentrum is a focused PatentsView assignee: 29 CPC subclasses with 55.7% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2019 (15 grants) versus a trough of 8 in 2024. By volume, Deutsches sits between Cognitive Scale, Inc. and Institut Curie.

Deutsches's three-year grant acceleration

From 2019–2021 to 2022–2024, Deutsches Krebsforschungszentrum moved from 36 to 29 grants (0.81x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,825. See the growth leaderboard.

Cognitive Scale

115
Coherent Logix In…

115
Coinbase

115
Desktop Metal

115
Dresser

115
Hisamitsu Pharmac…

115
Hunter Engineering

115
Institut Curie

115
Deutsches Krebsfo… ◀

115

What this shows Deutsches holds 115 patents at rank #3,253, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Deutsches

By rank, the assignees closest to #3,253 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Deutsches's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Deutsches, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (49 here).

Belimo Holding AG 49 Panasonic Healthcare Holdings Co., Ltd. 49 Dassault Systemes Simulia Corp. 49 Flir Belgium Bvba 49

Similar claim depth

Nearest assignees by average claims per patent (14.2 here).

SureFire, LLC 14.2 avg Pall Corporation 14.2 avg Universiteit Antwerpen 14.2 avg Gentex Corporation 14.2 avg

Deutsches's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 15% higher than 85% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Deutsches Krebsforschungszentrum patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	9	7.8%
2016	14	12.2%
2017	14	12.2%
2018	9	7.8%
2019	15	13.0%
2020	11	9.6%
2021	10	8.7%
2022	10	8.7%
2023	11	9.6%
2024	8	7.0%
2025partial year	4	3.5%

Which technologies does Deutsches Krebsforschungszentrum patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 64

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 62

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 45

C07K - Peptides 42

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 30

C07D - Heterocyclic Compounds 23

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 13

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 10

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 8

G02B - Optical Elements, Systems OR Apparatus 7

A61B - DIAGNOSIS; SURGERY; Identification 5

G21K - Techniques FOR Handling Particles OR Ionising Radiation NOT Otherwise Provided FOR; Irradiation DEVICES; Gamma RAY OR X-ray Microscopes 5

C12Y - Enzymes 3

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

C07C - Acyclic OR Carbocyclic Compounds 1

Top 15 of 29 technology areas

Where it ranks

Overall rank by patents

#3,253

of 49,997 tracked assignees

Innovation Score

49.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Deutsches Krebsforschungszentrum's patent record in context - here's where to go next.

Deutsches Krebsforschungszentrum's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 55.7% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #3,253 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Deutsches Krebsforschungszentrum against Cognitive Scale, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 49.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.